Treatment for stage 2–3 pressure ulcers
Part of Hormones & metabolism, Skin clinical trials.
This study tests a new medication called GM-XANTHO for treating stage 2–3 pressure ulcers (bedsores) in hospitalized or long-term care patients. It aims to see if the drug helps heal these wounds effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older and currently staying in a hospital or long-term care facility.
- You have at least one pressure ulcer (bedsore) that is stage 2 or 3, and it is between 2 and 5 centimeters across.
- You are willing to stop using other treatments on the ulcer (like special creams or light therapy) and avoid certain medications (like steroids) during the study.
- Your blood test results are within the required limits, and your ulcer has good blood flow (especially if it's on your leg or foot).
- If you have diabetes, your blood sugar control (HbA1c) must be 10% or lower and stable for at least 12 weeks.
- You agree to use effective birth control during the study and for 4 weeks after treatment if you or your partner can become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different wound-healing products (called CAMPs) to see if they work better than standard care for hard-to-heal pressure ulcers (bedsores). It might be a good fit if you have a long-lasting stage 3 or 4 bedsore on your trunk that is not infected.
This trial tests a new product (EDX110) to help heal diabetic foot ulcers that haven't improved with standard care. It's for people with diabetes who have a non-infected or mildly infected ulcer on their foot.
This study tests a new wound dressing made from amniotic membrane, called Xcell Amnio Matrix, to see if it helps heal diabetic foot ulcers that have not healed with standard treatments. If you qualify, you would receive the dressing along with regular wound care.
This trial tests a new skin graft material called NeoThelium FT to help heal pressure sores that aren't improving with standard care. The goal is to see if this treatment can speed up healing and improve your quality of life.
This trial tests if special wound dressings (called cellular, acellular, or matrix-like products) can help heal severe pressure ulcers that haven't improved with standard care. It may be a good option if you have a stage 3 or 4 pressure ulcer on your lower back or tailbone area that's been there for at least a month.
This trial tests a new skin graft called NeoThelium FT for stage 2 or 3 pressure ulcers on the pelvis or lower leg. It’s for adults whose wounds are not infected and who can use a wound vacuum to help healing.
Hear when a new Pressure Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.